These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8642184)

  • 1. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
    Gueyffier F; Froment A; Gouton M
    J Hum Hypertens; 1996 Jan; 10(1):1-8. PubMed ID: 8642184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic trials in arterial hypertension].
    Gueyffier F
    Rev Prat; 1999 Mar; 49(5):512-8. PubMed ID: 10358401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.
    Lièvre M; Gueyffier F; Ekbom T; Fagard R; Cutler J; Schron E; Marre M; Boissel JP
    Diabetes Care; 2000 Apr; 23 Suppl 2():B65-71. PubMed ID: 10860193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative placebo comparison of the SCOPE and LIFE trials.
    Meredith PA; Murray LS; McMurray JJ; ;
    J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):59-63. PubMed ID: 15295716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension.
    Hoes AW; Grobbee DE; Lubsen J
    J Hypertens; 1995 Jul; 13(7):805-11. PubMed ID: 7594445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease.
    MacMahon S; Neal B; Rodgers A
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2479-86. PubMed ID: 8571098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
    Bejan-Angoulvant T; Saadatian-Elahi M; Wright JM; Schron EB; Lindholm LH; Fagard R; Staessen JA; Gueyffier F
    J Hypertens; 2010 Jul; 28(7):1366-72. PubMed ID: 20574244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials?
    Staessen JA; Wang J
    J Nephrol; 2002; 15(4):422-7. PubMed ID: 12243374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension trial results: consensus and conflicts.
    Dollery C
    J Hum Hypertens; 1995 Jun; 9(6):403-8. PubMed ID: 7473518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.
    Staessen JA; Li Y; Thijs L; Wang JG
    Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.